Skip to main content
Top
Published in: Immunologic Research 1/2019

01-02-2019 | Original Article

Positive correlation between interleukin-1 receptor antagonist gene 86bp VNTR polymorphism and colorectal cancer susceptibility: a case-control study

Authors: Mostafa Ibrahimi, Maryam Moossavi, Ehsan Nazemalhosseini Mojarad, Mahsa Musavi, Milad Mohammadoo-khorasani, Zahra Shahsavari

Published in: Immunologic Research | Issue 1/2019

Login to get access

Abstract

Colorectal cancer (CRC) is one of the most common malignancies worldwide. Genetic variations in cytokine genes and their receptors lead to the severity of the disease. The interleukin-1 receptor antagonist (IL1RN) is a cytokine that inhibits interleukin-1 (IL-1) activity by binding to IL-1 receptors. Also, interleukin-4 (IL-4) is an anti-inflammatory cytokine that can play an important role in several cancers. The present case-control study was aimed to evaluate the association of IL-4 and IL1RN VNTR polymorphisms with the susceptibility to CRC in a sample of Iranian population provided by the Research Center for Gastroenterology and Liver Disease at Taleghani Hospital, Tehran. A total of 123 patients diagnosed with CRC and 152 healthy controls were recruited in the present study. Genomic DNA was extracted by salting out method from whole blood and genotyping of IL1RN and IL-4 VNTR polymorphisms were determined by PCR-based technology. Our study manifested the frequency of 1/2 and 2/4 genotypes of IL1RN 68bp VNTR polymorphism are significantly different between both groups (p = 0.0001 and p = 0.01 respectively). However, we could not find any correlation between IL-4 VNTR polymorphism and CRC cancer. It seems that 1/2 and 2/4 genotypes of IL1RN are correlated with CRC susceptibility in our population, although, more studies are needed to confirm our results.
Literature
2.
go back to reference Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRef Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRef
3.
go back to reference Rafiemanesh H, Pakzad R, Abedi M, Kor Y, Moludi J, Towhidi F, et al. Colorectal cancer in Iran: epidemiology and morphology trends. EXCLI J. 2016;15:738.PubMedPubMedCentral Rafiemanesh H, Pakzad R, Abedi M, Kor Y, Moludi J, Towhidi F, et al. Colorectal cancer in Iran: epidemiology and morphology trends. EXCLI J. 2016;15:738.PubMedPubMedCentral
4.
go back to reference Shadmani FK, Ayubi E, Khazaei S, Sani M, Hanis SM, Khazaei S et al. Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study. Epidemiol Health 2017;39. Shadmani FK, Ayubi E, Khazaei S, Sani M, Hanis SM, Khazaei S et al. Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study. Epidemiol Health 2017;39.
5.
go back to reference Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health. 2015;15(1):997.CrossRefPubMedPubMedCentral Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health. 2015;15(1):997.CrossRefPubMedPubMedCentral
6.
go back to reference Brenner DR, Scherer D, Muir K, Schildkraut J, Boffetta P, Spitz MR et al. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Prev Biomarkers. 2014:cebp 0064.2014. Brenner DR, Scherer D, Muir K, Schildkraut J, Boffetta P, Spitz MR et al. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Prev Biomarkers. 2014:cebp 0064.2014.
7.
go back to reference Mager LF, Wasmer M-H, Rau TT, Krebs P. Cytokine-induced modulation of colorectal cancer. Front Oncol. 2016;6. Mager LF, Wasmer M-H, Rau TT, Krebs P. Cytokine-induced modulation of colorectal cancer. Front Oncol. 2016;6.
8.
go back to reference Stubljar D, Jeverica S, Jukic T, Skvarc M, Pintar T, Tepes B, et al. The influence of cytokine gene polymorphisms on the risk of developing gastric cancer in patients with Helicobacter pylori infection. Radiol Oncol. 2015;49(3):256–64.CrossRefPubMedPubMedCentral Stubljar D, Jeverica S, Jukic T, Skvarc M, Pintar T, Tepes B, et al. The influence of cytokine gene polymorphisms on the risk of developing gastric cancer in patients with Helicobacter pylori infection. Radiol Oncol. 2015;49(3):256–64.CrossRefPubMedPubMedCentral
9.
go back to reference Gupta MK, Singh R, Banerjee M. Cytokine gene polymorphisms and their association with cervical cancer: a North Indian study. Egypt J Med Human Gen. 2016;17(2):155–63.CrossRef Gupta MK, Singh R, Banerjee M. Cytokine gene polymorphisms and their association with cervical cancer: a North Indian study. Egypt J Med Human Gen. 2016;17(2):155–63.CrossRef
10.
go back to reference Marszałek A, Szylberg Ł, Wiśniewska E, Janiczek M. Impact of COX-2, IL-1β, TNF-α, IL-4 and IL-10 on the process of carcinogenesis in the large bowel. Pol J Pathol. 2012;63(4):221–7.CrossRefPubMed Marszałek A, Szylberg Ł, Wiśniewska E, Janiczek M. Impact of COX-2, IL-1β, TNF-α, IL-4 and IL-10 on the process of carcinogenesis in the large bowel. Pol J Pathol. 2012;63(4):221–7.CrossRefPubMed
11.
go back to reference Mohammadoo-Khorasani M, Salimi S, Tabatabai E, Sandoughi M, Zakeri Z, Farajian-Mashhadi F. Interleukin-1β (IL-1β) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE. Indian J Med Res. 2016;143(5):591–6.CrossRefPubMedPubMedCentral Mohammadoo-Khorasani M, Salimi S, Tabatabai E, Sandoughi M, Zakeri Z, Farajian-Mashhadi F. Interleukin-1β (IL-1β) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE. Indian J Med Res. 2016;143(5):591–6.CrossRefPubMedPubMedCentral
12.
go back to reference Olver S, Apte S, Baz A, Kienzle N. The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth? HLA. 2007;69(4):293–8. Olver S, Apte S, Baz A, Kienzle N. The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth? HLA. 2007;69(4):293–8.
13.
go back to reference Salimi S, Mohammadoo-Khorasani M, Yaghmaei M, Mokhtari M, Moossavi M. Possible association of IL-4 VNTR polymorphism with susceptibility to preeclampsia. Biomed Res Int. 2014;2014:1–5. Salimi S, Mohammadoo-Khorasani M, Yaghmaei M, Mokhtari M, Moossavi M. Possible association of IL-4 VNTR polymorphism with susceptibility to preeclampsia. Biomed Res Int. 2014;2014:1–5.
14.
go back to reference Viet HT, Wågsäter D, Hugander A, Dimberg J. Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer. Oncol Rep. 2005;14(4):915–8.PubMed Viet HT, Wågsäter D, Hugander A, Dimberg J. Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer. Oncol Rep. 2005;14(4):915–8.PubMed
15.
go back to reference Patterson D, Jones C, Hart I, Bleskan J, Berger R, Geyer D, et al. The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region. Genomics. 1993;15(1):173–6.CrossRefPubMed Patterson D, Jones C, Hart I, Bleskan J, Berger R, Geyer D, et al. The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region. Genomics. 1993;15(1):173–6.CrossRefPubMed
16.
go back to reference Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 1993;91(4):403–4.CrossRefPubMed Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 1993;91(4):403–4.CrossRefPubMed
17.
go back to reference El-Omar EM, Carrington M, Chow W-H, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404(6776):398–402.CrossRefPubMed El-Omar EM, Carrington M, Chow W-H, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404(6776):398–402.CrossRefPubMed
18.
go back to reference Zhang Y, Liu C, Peng H, Zhang J, Feng Q. IL1 receptor antagonist gene IL1-RN variable number of tandem repeats polymorphism and cancer risk: a literature review and meta-analysis. PLoS One. 2012;7(9):e46017.CrossRefPubMedPubMedCentral Zhang Y, Liu C, Peng H, Zhang J, Feng Q. IL1 receptor antagonist gene IL1-RN variable number of tandem repeats polymorphism and cancer risk: a literature review and meta-analysis. PLoS One. 2012;7(9):e46017.CrossRefPubMedPubMedCentral
19.
go back to reference Kok Y-Y, Ong H-H, Say Y-H. Interleukin-1 receptor antagonist and interleukin-4 genes variable number tandem repeats are associated with adiposity in Malaysian subjects. J Obes. 2017;2017:1–8.CrossRef Kok Y-Y, Ong H-H, Say Y-H. Interleukin-1 receptor antagonist and interleukin-4 genes variable number tandem repeats are associated with adiposity in Malaysian subjects. J Obes. 2017;2017:1–8.CrossRef
20.
go back to reference Ma J, Sun X, Guo T, Su H, Chen Q, Gong Z, et al. Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κβ pathway in human colon cancer cell. Cancer Manag Res. 2017;9:481–93.CrossRefPubMedPubMedCentral Ma J, Sun X, Guo T, Su H, Chen Q, Gong Z, et al. Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κβ pathway in human colon cancer cell. Cancer Manag Res. 2017;9:481–93.CrossRefPubMedPubMedCentral
21.
go back to reference Jahantigh D, Salimi S, Mousavi M, Moossavi M, Mohammadoo-Khorasani M, Narooei-nejad M, et al. Association between functional polymorphisms of DNA double-strand breaks in repair genes XRCC5, XRCC6 and XRCC7 with the risk of systemic lupus erythematosus in South East Iran. DNA Cell Biol. 2015;34(5):360–6.CrossRefPubMed Jahantigh D, Salimi S, Mousavi M, Moossavi M, Mohammadoo-Khorasani M, Narooei-nejad M, et al. Association between functional polymorphisms of DNA double-strand breaks in repair genes XRCC5, XRCC6 and XRCC7 with the risk of systemic lupus erythematosus in South East Iran. DNA Cell Biol. 2015;34(5):360–6.CrossRefPubMed
22.
go back to reference Salimi S, Mohammadoo-Khorasani M, Mousavi M, Yaghmaei M, Mokhtari M, Farajian-Mashhadi F. Association of interleukin-1 receptor antagonist VNTR polymorphism and risk of pre-eclampsia in southeast Iranian population. J Obstet Gynaecol Res. 2016;42(2):142–7.CrossRefPubMed Salimi S, Mohammadoo-Khorasani M, Mousavi M, Yaghmaei M, Mokhtari M, Farajian-Mashhadi F. Association of interleukin-1 receptor antagonist VNTR polymorphism and risk of pre-eclampsia in southeast Iranian population. J Obstet Gynaecol Res. 2016;42(2):142–7.CrossRefPubMed
23.
go back to reference Bredberg A. Cancer: more of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer. 2011;117(3):440–5.CrossRefPubMed Bredberg A. Cancer: more of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer. 2011;117(3):440–5.CrossRefPubMed
24.
go back to reference Ogino S, Galon J, Fuchs CS, Dranoff G. Cancer immunology—analysis of host and tumor factors for personalized medicine. Nat Rev Clin Oncol. 2011;8(12):711–9.CrossRefPubMedPubMedCentral Ogino S, Galon J, Fuchs CS, Dranoff G. Cancer immunology—analysis of host and tumor factors for personalized medicine. Nat Rev Clin Oncol. 2011;8(12):711–9.CrossRefPubMedPubMedCentral
25.
go back to reference Duan Y, Pan C, Shi J, Chen H, Zhang S. Association between interleukin-4 gene intron 3 VNTR polymorphism and cancer risk. Cancer Cell Int. 2014;14(1):131.CrossRefPubMedPubMedCentral Duan Y, Pan C, Shi J, Chen H, Zhang S. Association between interleukin-4 gene intron 3 VNTR polymorphism and cancer risk. Cancer Cell Int. 2014;14(1):131.CrossRefPubMedPubMedCentral
26.
go back to reference Hughes LA, Simons CC, van den Brandt PA, van Engeland M, Weijenberg MP. Lifestyle, diet, and colorectal cancer risk according to (epi) genetic instability: current evidence and future directions of molecular pathological epidemiology. Curr Colorectal Cancer Rep. 2017;13(6):455–69.CrossRefPubMedPubMedCentral Hughes LA, Simons CC, van den Brandt PA, van Engeland M, Weijenberg MP. Lifestyle, diet, and colorectal cancer risk according to (epi) genetic instability: current evidence and future directions of molecular pathological epidemiology. Curr Colorectal Cancer Rep. 2017;13(6):455–69.CrossRefPubMedPubMedCentral
27.
go back to reference Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2011;60(3):397–411.CrossRefPubMed Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2011;60(3):397–411.CrossRefPubMed
28.
go back to reference Gopal M. Role of cytokines in tumor immunity and immune tolerance to cancer. Cancer immunology. Springer; 2015. p. 93–119. Gopal M. Role of cytokines in tumor immunity and immune tolerance to cancer. Cancer immunology. Springer; 2015. p. 93–119.
29.
go back to reference Yigit M, Değirmencioğlu S, Ugurlu E, Yaren A. Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancer. Molecular and Clinical Oncology. 2017;6(5):708–12.CrossRefPubMedPubMedCentral Yigit M, Değirmencioğlu S, Ugurlu E, Yaren A. Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancer. Molecular and Clinical Oncology. 2017;6(5):708–12.CrossRefPubMedPubMedCentral
30.
go back to reference Hallett MA, Venmar KT, Fingleton B. Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. Cancer Res. 2012;72(24):6338–43.CrossRefPubMedPubMedCentral Hallett MA, Venmar KT, Fingleton B. Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. Cancer Res. 2012;72(24):6338–43.CrossRefPubMedPubMedCentral
31.
go back to reference Ahmed AB, Zidi S, Ghazouani E, Mezlini A, Lagha A, Bouraoui S et al. Interleukin-1 receptor antagonist VNTR polymorphism and ovarian cancer susceptibility in Tunisian women. 2014. Ahmed AB, Zidi S, Ghazouani E, Mezlini A, Lagha A, Bouraoui S et al. Interleukin-1 receptor antagonist VNTR polymorphism and ovarian cancer susceptibility in Tunisian women. 2014.
32.
go back to reference Yang C-M, Chen H-C, Hou Y-Y, Lee M-C, Liou H-H, Huang S-J, et al. A high IL-4 production diplotype is associated with an increased risk but better prognosis of oral and pharyngeal carcinomas. Arch Oral Biol. 2014;59(1):35–46.CrossRefPubMed Yang C-M, Chen H-C, Hou Y-Y, Lee M-C, Liou H-H, Huang S-J, et al. A high IL-4 production diplotype is associated with an increased risk but better prognosis of oral and pharyngeal carcinomas. Arch Oral Biol. 2014;59(1):35–46.CrossRefPubMed
33.
go back to reference Bhayal AC, Krishnaveni D, Rao KPR, Kumar AR, Jyothy A, Nallari P, et al. Significant association of interleukin4 intron 3 VNTR polymorphism with susceptibility to gastric cancer in a South Indian population from Telangana. PLoS One. 2015;10(9):e0138442.CrossRefPubMedPubMedCentral Bhayal AC, Krishnaveni D, Rao KPR, Kumar AR, Jyothy A, Nallari P, et al. Significant association of interleukin4 intron 3 VNTR polymorphism with susceptibility to gastric cancer in a South Indian population from Telangana. PLoS One. 2015;10(9):e0138442.CrossRefPubMedPubMedCentral
34.
go back to reference Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 2007;356(21):2131–42.CrossRefPubMed Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 2007;356(21):2131–42.CrossRefPubMed
Metadata
Title
Positive correlation between interleukin-1 receptor antagonist gene 86bp VNTR polymorphism and colorectal cancer susceptibility: a case-control study
Authors
Mostafa Ibrahimi
Maryam Moossavi
Ehsan Nazemalhosseini Mojarad
Mahsa Musavi
Milad Mohammadoo-khorasani
Zahra Shahsavari
Publication date
01-02-2019
Publisher
Springer US
Published in
Immunologic Research / Issue 1/2019
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-018-9034-3

Other articles of this Issue 1/2019

Immunologic Research 1/2019 Go to the issue